Discover

MIST
Milestone Pharmaceuticals Inc.
1.27
50 x 1.10
30 x 1.28
bid
ask
+
0.01
0.79%
1765 @ 04:00 PM
1.24 -0.03 (2.36%)
Ytd-37.13%
1y-18.06%
1.25
day range
1.27
1.00
52 week range
3.06
Open1.27Prev Close1.26Low1.25High1.27Mkt Cap158.11M
Vol0.00Avg Vol1.38MEPS-0.68P/E-1.87Forward P/E-2.15
Beta1.73Short Ratio2.46Inst. Own57.01%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning08-1250-d Avg1.24200-d Avg1.731yr Est10.25

MIST News

Milestone Pharmaceuticals to Announce Second Quarter 2026 Financial Results on August 12, 2026
globenewswire.com
Milestone Pharmaceuticals to Announce Second Quarter 2026 Financial Results on August 12, 2026

MONTREAL and CHARLOTTE, N.C., Aug. 04, 2026 (GLOBE NEWSWIRE) -- Milestone® Pharmaceuticals Inc. (Nas

After Plunging 20.2% in 4 Weeks, Here's Why the Trend Might Reverse for Milestone Pharmaceuticals (MIST)
zacks.com
After Plunging 20.2% in 4 Weeks, Here's Why the Trend Might Reverse for Milestone Pharmaceuticals (M

Milestone Pharmaceuticals (MIST) has become technically an oversold stock now, which implies exhaust

12 Health Care Stocks Moving In Tuesday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Tuesday's After-Market Session

Gainers Catheter Precision (AMEX:VTAK) shares moved upwards by 34.7% to $0.96 during Tuesday's

Milestone Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
Milestone Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

MONTREAL and CHARLOTTE, N. C. , July 02, 2026 (GLOBE NEWSWIRE) -- Milestone Pharmaceuticals Inc. (Na

Alpha Cognition Announces Election of Dr. Robert Wills as Chairman of the Board
gurufocus.com
Alpha Cognition Announces Election of Dr. Robert Wills as Chairman of the Board

Alpha Cognition Inc. (Nasdaq: ACOG) (“Alpha Cognition”, or the “Company”), a biopharmaceutic

Milestone Pharmaceuticals Inc. (MIST) Shareholder/Analyst Call Prepared Remarks Transcript
seekingalpha.com
Milestone Pharmaceuticals Inc. (MIST) Shareholder/Analyst Call Prepared Remarks Transcript

Milestone Pharmaceuticals Inc. (MIST) Shareholder/Analyst Call Prepared Remarks Transcript

Milestone Pharmaceuticals: Here Comes The Revenue Ramp
seekingalpha.com
Milestone Pharmaceuticals: Here Comes The Revenue Ramp

Milestone Pharmaceuticals Inc. remains a Strong Buy, despite recent volatility and a 37% stock decli

Milestone Pharmaceuticals to Present at the H.C. Wainwright 4th Annual BioConnect Investor Conference at NASDAQ
globenewswire.com
Milestone Pharmaceuticals to Present at the H.C. Wainwright 4th Annual BioConnect Investor Conferenc

MONTREAL and CHARLOTTE, N.C., May 14, 2026 (GLOBE NEWSWIRE) -- Milestone® Pharmaceuticals Inc. (Nasd

Why Milestone Pharmaceuticals Stock Wilted on Wednesday
fool.com
Why Milestone Pharmaceuticals Stock Wilted on Wednesday

The biotech fell well short of analyst projections in the first quarter.

Milestone Pharmaceuticals Q1 Earnings Call Highlights
marketbeat.com
Milestone Pharmaceuticals Q1 Earnings Call Highlights

Milestone Pharmaceuticals NASDAQ: MIST said its first quarter of 2026 marked the beginning of commer

Milestone Pharmaceuticals Inc. (MIST) Q1 2026 Earnings Call Transcript
seekingalpha.com
Milestone Pharmaceuticals Inc. (MIST) Q1 2026 Earnings Call Transcript

Milestone Pharmaceuticals Inc. (MIST) Q1 2026 Earnings Call Transcript

Milestone Reports Q1 Results, Highlights Initial CARDAMYST Sales
benzinga.com
Milestone Reports Q1 Results, Highlights Initial CARDAMYST Sales

Milestone Pharmaceuticals Inc. (NASDAQ:MIST) reported first-quarter earnings on Wednesday before the

Milestone Pharmaceuticals (MIST) Reports Q1 Loss, Lags Revenue Estimates
zacks.com
Milestone Pharmaceuticals (MIST) Reports Q1 Loss, Lags Revenue Estimates

Milestone Pharmaceuticals (MIST) came out with a quarterly loss of $0.2 per share versus the Zacks C

12 Health Care Stocks Moving In Wednesday's Pre-Market Session
benzinga.com
12 Health Care Stocks Moving In Wednesday's Pre-Market Session

Earnings Scheduled For May 13, 2026
benzinga.com
Earnings Scheduled For May 13, 2026

Milestone Pharmaceuticals Announces First Quarter 2026 Financial Results and Provides Corporate Update
globenewswire.com
Milestone Pharmaceuticals Announces First Quarter 2026 Financial Results and Provides Corporate Upda

MONTREAL and CHARLOTTE, N.C., May 13, 2026 (GLOBE NEWSWIRE) -- Milestone® Pharmaceuticals Inc. (Nasd

Milestone Pharmaceuticals to Announce First Quarter 2026 Financial Results on May 13, 2026
globenewswire.com
Milestone Pharmaceuticals to Announce First Quarter 2026 Financial Results on May 13, 2026

MONTREAL and CHARLOTTE, May 06, 2026 (GLOBE NEWSWIRE) -- Milestone® Pharmaceuticals Inc. (Nasdaq: MI

Milestone Pharmaceuticals Inc. (NASDAQ:MIST) Receives Average Rating of “Moderate Buy” from Analysts
defenseworld.net
Milestone Pharmaceuticals Inc. (NASDAQ:MIST) Receives Average Rating of “Moderate Buy” from Analysts

Shares of Milestone Pharmaceuticals Inc. (NASDAQ: MIST - Get Free Report) have been assigned an aver

Milestone Pharmaceuticals Announces RESET-PSVT Registry to Generate Real-World Evidence on CARDAMYST™ (etripamil) Nasal Spray in Patients With PSVT
globenewswire.com
Milestone Pharmaceuticals Announces RESET-PSVT Registry to Generate Real-World Evidence on CARDAMYST

Registry Study Design Presented at the Preventive Cardiovascular Nurses Association 2026 Cardiovascu

Milestone Pharmaceuticals to Present at the 25th Annual Needham Virtual Healthcare Conference
globenewswire.com
Milestone Pharmaceuticals to Present at the 25th Annual Needham Virtual Healthcare Conference

MONTREAL and CHARLOTTE, N.C., April 07, 2026 (GLOBE NEWSWIRE) -- Milestone® Pharmaceuticals Inc. (Na

Milestone Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
Milestone Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

MONTREAL and CHARLOTTE, N.C., April 02, 2026 (GLOBE NEWSWIRE) -- Milestone Pharmaceuticals Inc. (Nas

Milestone Pharmaceuticals Announces that CARDAMYST™ (etripamil) Nasal Spray is Available on Express Scripts Commercial National Formularies
globenewswire.com
Milestone Pharmaceuticals Announces that CARDAMYST™ (etripamil) Nasal Spray is Available on Express

MONTREAL and CHARLOTTE, N.C., March 31, 2026 (GLOBE NEWSWIRE) -- Milestone® Pharmaceuticals Inc. (Na

Why Milestone Pharma Stock Is Taking A Dive Today
benzinga.com
Why Milestone Pharma Stock Is Taking A Dive Today

EU decision delay for Milestone Pharmaceuticals etripamil, despite strong U.S. launch progress, soli

Earnings Scheduled For March 20, 2026
benzinga.com
Earnings Scheduled For March 20, 2026

12 Health Care Stocks Moving In Tuesday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Tuesday's After-Market Session

12 Health Care Stocks Moving In Friday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Friday's Intraday Session

benzinga.com
12 Health Care Stocks Moving In Friday's Intraday Session

benzinga.com
12 Health Care Stocks Moving In Friday's Pre-Market Session

benzinga.com
Why Butterfly Network Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Thursday's Mi

Shares of Butterfly Network, Inc. (NASDAQ: BFLY) fell sharply during Thursday’s session after the

benzinga.com
Top 5 Health Care Stocks That Could Lead To Your Biggest Gains in January

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued c

benzinga.com
Why Alibaba Shares Are Trading Higher By Over 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day

Gainers

benzinga.com
Stocks That Hit 52-Week Lows On Friday

  On Friday, 135 companies reached new 52-week lows.

benzinga.com
Stocks That Hit 52-Week Lows On Monday

  Monday saw 196 companies set new 52-week lows.

benzinga.com
This Biotechnology Stock Tumbled 37%; Here Are 70 Biggest Movers From Yesterday

Gainers Bright Minds Biosciences Inc. (NASDAQ: DRUG) shares climbed 135.9% to close at $2.17 on T

benzinga.com
Stocks That Hit 52-Week Lows On Tuesday

Stocks That Hit 52-Week Lows On Tuesday

benzinga.com
Stocks That Hit 52-Week Lows On Friday

Stocks That Hit 52-Week Lows On Friday